undamentalytics Newsletter
Sign in

Zimmer Biomet cash flow statement

In fiscal 2025, Zimmer Biomet's operations generated $1.70bn of cash; it spent $225m on capital projects, leaving free cash flow of $1.47bn. It returned $190m in dividends and $487m through buybacks.

Cash flow statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2007Dec 20072008Dec 20082009Dec 20092010Dec 20102016Dec 20162017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Cash from operations1,0841,0381,1181,1941,6321,5821,7471,5861,2051,4991,3561,5821,4991,6971,743
Depreciation and amortisation2302753373401,0391,0631,0411,0068989389269529961,0941,108
Stock-based pay707075625754668474761051001019098
Capital spending19325010579185156163207112144188291204225220
Free cash flow8927881,0121,1141,4481,4261,5851,3791,0931,3561,1681,2911,2961,4731,523
Free cash flow after stock pay8227189371,0521,3901,3731,5191,2941,0191,2801,0631,1911,1951,3821,425
Dividends paid————188194195197199200201201196190188
Share buybacks576737924506416—————126692868487751

Free cash flow is cash from operations minus capital spending. Free cash flow after stock pay also subtracts stock-based compensation, a real cost to shareholders that the cash flow statement adds back. Dividends, buybacks and shares issued are cash amounts for the period.

Compare with peers

Head to head: ALC vs ZBHEW vs ZBHISRG vs ZBHBAX vs ZBH

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Zimmer Biomet's SEC filings (10-K and 10-Q), retrieved October 20, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Zimmer Biomet.